Two Chinks in the Armor of Hepatitis C
In the middle ages, a great time to attack one's enemies is while they were sleeping. Researchers have found two times when the hepatitis C vaccine may be easily attacked.
Half the Dose for Hepatitis C Remission
Less sometimes is worth more! Finding the "sweet spot" for taking a drug while minimizing the downside of drug exposure is the goal of many drug researchers. A new multi-continent study has done just.
Cryptic Infection Missed in AIDS Patients
For patients with AIDS, a fungal infection can be a major problem. However, researchers may have found a way to make treatement more likely to succeed by identifying a new cause.
FDA Hepatitis Update - Pegasys and Copegus
On August 22, 2011, the FDA approved the combination of Pegasys and Copegus for the treatment of chronic hepatitis C virus ( HCV ) infection in pediatric patients 5 through 17 years of age.
Cholesterol Conundrum with HIV Kids
New treatments can enable children born with HIV to live well into their adult years, but the antiretroviral therapy (ART) can cause high cholesterol. Researchers are urging early cholesterol monitoring for these kids.
Complera Approval Completed
Gilead Sciences announces Complera, a new daily pill for HIV-1 infected adults with no prior antiretroviral therapies, has been approved by the FDA.
Blocking Out Chlamydia
To say that chlamydia is a big player in sexually transmitted diseases is a huge understatement. Chlamydia is responsible for the largest number of sexually-transmitted infections.
Reyataz Equal Opportunity Protector
Most women living with HIV are in their childbearing years. This makes the effectiveness of their HIV treatment and benefits to their unborn children particularly important.
Preemie Problems With HIV Drug
Premature babies can be born with a host of problems. Preemies exposed to HIV through their mothers also have even more complicated beginnings.
Hepatitis B Vaccine for Pregnant Women
When women become pregnant, they often focus their energies on making sure their fetus is as healthy as possible. However, by delaying vaccination for hepatitis B (HBV) while pregnant, women may be putting their own health at risk.